Page 658 - Clinical Application of Mechanical Ventilation
P. 658

624    Chapter	19


                                                 P INSP       30 cm H O
                                                                      2
                                                 F O 2        50%
                                                  I
                                                 PEEP         10 cm H O
                                                                      2
                                             She was becoming more alert and oriented to time and place and was appro-
                                            priately changed to SIMV with pressure support (PS) to supplement her own
                                            efforts to breathe. She appeared calm at first but became increasingly restless
                                            and combative over the afternoon and evening. She frequently motioned for
                                            the endotracheal tube to be removed and was frustrated about her inability
                                            to talk.

                                            Patient Management


                                            In addition to the ventilator management strategies, adequate hydration was pro-
                                            vided to promote mucociliary clearance and bronchopulmonary hygiene. Inhaled
                                            bronchodilators, glucocorticosteroids, and mast cell stabilizers (nonacutely) were
                                            used to bring the bronchospasm and inflammation under control.

                                            Key Medications


                                            The patient was treated with IV aminophylline, beta adrenergics (Proventil® and
                                            Serevent®)  via  MDI  and  given  inline  through  the  ventilator  circuit  every  3  to
                                            4 hours. These served to control the symptoms associated with asthma while she
                          Intal is not given in acute
                        asthma episodes but is used   was started on triacinolone acetonide (Azmacort®), a corticosteroid inhaler to con-
                        as a prophylactic measure   trol inflammation. She was also started on two puffs of cromolyn sodium (Intal®)
                        to control airway hyper-
                        reactivity.         to help prevent further degranulation of mast cell responsible for hyper-reactive
                                            airway disease and future attacks.

                                            Weaning


                                            The weaning process was uneventful as the patient continued to improve. She was
                                            eventually  placed  on  CPAP  without  pressure  support  for  extubation  trial.  Her
                                            spontaneous breathing parameters revealed the following results:

                                                f 5 15   V  5 8.1 L   Average V  5 0.54 L   VC 5 2.19 L    MIP 5 243 cm H O
                                                                         T
                                                      E
                                                                                                               2
                          An f/V T  ratio (RSBI or rapid   f/V  5 28/min/L
                        shallow breathing index) of   T
                        less than 100/min/L correlates   At some point, the patient extubated herself while being restrained. The decision
                        with weaning success.
                                            was made to provide nasal cannula at 6 L/min, which maintained her oxygen satura-
                                            tions above 90%.
                                            Complications


                                            Her oxygen demands decreased over several days where she continued with her
                                            bronchodilators, was weaned to room air, and was discharged after 6 days. There
                                            were no apparent complications throughout her hospital stay and she was advised






                        Copyright 2013 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
                      Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
   653   654   655   656   657   658   659   660   661   662   663